Industry News - Tag: AFT
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
24 September 2021
New Zealand’s AFT Pharmaceuticals has expanded its European business development team as it seeks to overcome the barriers to international business travel associated with the COVID-19 pandemic. In a separate development, the company has gained authorisations for its Maxigesic analgesic in Chile, Pa...
13 September 2021
Sun Pharma has entered the nutrition bar segment in India with its Revital brand, The Bountiful Company has extended Sundown Kids in the US, and AFT Pharmaceuticals is seeking a change to the classification of ibuprofen in New Zealand.
15 July 2021
Bausch Health Companies has extended its Biotrue eyecare brand in the US, Bayer Consumer Health is backing the launch of AleveX with a golf-themed campaign, and AFT Pharmaceuticals has received regulatory approval for Maxigesic Oral Liquid in two countries.
28 May 2021
AFT Pharmaceuticals reported sales up by 7% to NZD113 million (USD81.6 million) in the 12 months ended 31 March 2021. The New Zealand company said the tablet version of its Maxigesic combination painkiller was available in 43 countries at the end of the 12-month period, up from 28 a year earlier.
8 April 2021
New Zealand’s AFT Pharmaceuticals has signed a licensing agreement for its Maxigesic combination painkiller with Polish company Mercapharm. The company has also revised its financial guidance following delays and disruptions related to the COVID-19 pandemic.